[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ID27996A - Polimorf dari suatu bahan farmasi - Google Patents

Polimorf dari suatu bahan farmasi

Info

Publication number
ID27996A
ID27996A ID20010165A ID20010165A ID27996A ID 27996 A ID27996 A ID 27996A ID 20010165 A ID20010165 A ID 20010165A ID 20010165 A ID20010165 A ID 20010165A ID 27996 A ID27996 A ID 27996A
Authority
ID
Indonesia
Prior art keywords
polymorf
pharmaceutical material
pharmaceutical
Prior art date
Application number
ID20010165A
Other languages
English (en)
Inventor
John F Bauer
Azita Saleki-Gerhard
Bikshandarkoit
Sanjay R Chemburkar
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26817251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27996(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ID27996A publication Critical patent/ID27996A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
ID20010165A 1998-07-20 1999-07-19 Polimorf dari suatu bahan farmasi ID27996A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11934598A 1998-07-20 1998-07-20
US32609399A 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
ID27996A true ID27996A (id) 2001-05-03

Family

ID=26817251

Family Applications (1)

Application Number Title Priority Date Filing Date
ID20010165A ID27996A (id) 1998-07-20 1999-07-19 Polimorf dari suatu bahan farmasi

Country Status (30)

Country Link
EP (4) EP1418174B1 (id)
JP (4) JP4815050B2 (id)
KR (3) KR100853371B1 (id)
CN (5) CN1502613A (id)
AR (5) AR019431A1 (id)
AT (3) ATE261947T1 (id)
AU (1) AU768207B2 (id)
BG (4) BG65150B1 (id)
BR (1) BR9912010A (id)
CA (3) CA2510949C (id)
CO (1) CO5090830A1 (id)
CY (2) CY1111600T1 (id)
CZ (2) CZ307116B6 (id)
DE (2) DE69915628T2 (id)
DK (3) DK2017269T3 (id)
ES (3) ES2214038T3 (id)
HK (2) HK1037918A1 (id)
HU (3) HU227540B1 (id)
ID (1) ID27996A (id)
IL (4) IL140492A0 (id)
MY (2) MY145265A (id)
NO (2) NO318385B1 (id)
NZ (2) NZ509125A (id)
PL (2) PL213978B1 (id)
PT (3) PT1418174E (id)
SI (3) SI1418174T1 (id)
SK (3) SK287586B6 (id)
TR (1) TR200100171T2 (id)
TW (3) TWI362382B (id)
WO (1) WO2000004016A2 (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894171B1 (en) 1998-07-20 2005-05-17 Abbott Laboratories Polymorph of a pharmaceutical
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
EP1183026B1 (en) * 1999-06-04 2006-07-05 Abbott Laboratories Improved pharmaceutical formulations comprising ritonavir
EP1395249A1 (en) * 2001-05-25 2004-03-10 Abbott Laboratories Soft elastic capsules comprising ritonavir and/or lopinavir
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
US7205413B2 (en) 2002-05-03 2007-04-17 Transform Pharmaceuticals, Inc. Solvates and polymorphs of ritonavir and methods of making and using the same
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
BRPI0401742B8 (pt) 2004-05-13 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir
EP1891027A1 (en) * 2005-05-30 2008-02-27 Ranbaxy Laboratories Limited Processes for the preparation of stable polymorphic form i of ritonavir
US20100099885A1 (en) * 2006-10-03 2010-04-22 Mukesh Kumar Sharma Process for the preparation of form i and form ii of ritonavir
CN102898398B (zh) * 2011-07-27 2015-01-14 上海迪赛诺药业有限公司 一种制备i型利托那韦多晶型结晶的方法
EP2822553B1 (en) 2012-03-07 2016-05-18 ratiopharm GmbH Dosage form comprising non-crystalline lopinavir and crystalline ritonavir
US9370578B2 (en) 2012-03-07 2016-06-21 Ratiopharm Gmbh Dosage form comprising lopinavir and ritonavir
CA2918707A1 (en) 2013-08-29 2015-03-05 Teva Pharmaceuticals Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
WO2015155673A1 (en) 2014-04-08 2015-10-15 Teva Pharmaceutical Industries Ltd Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN106749085B (zh) * 2016-12-23 2019-05-24 东北制药集团股份有限公司 一种制备利托那韦的方法
EP3569225A1 (en) 2018-05-18 2019-11-20 Pharmaceutical Oriented Services Ltd Solid dispersion containing ritonavir
RU2759544C1 (ru) * 2021-01-29 2021-11-15 Общество с ограниченной ответственностью "АМЕДАРТ" Твёрдая фармацевтическая композиция для изготовления перорального терапевтического средства для профилактики и/или лечения ВИЧ-инфекции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539122A (en) * 1989-05-23 1996-07-23 Abbott Laboratories Retroviral protease inhibiting compounds
US5354866A (en) 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
DK1090914T3 (da) * 1992-12-29 2003-04-22 Abbott Lab Forbindelser, der inhiberer retroviral protease
IL110752A (en) 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
US5491253A (en) 1993-10-22 1996-02-13 Abbott Laboratories Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
IL111991A (en) 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
US5567823A (en) * 1995-06-06 1996-10-22 Abbott Laboratories Process for the preparation of an HIV protease inhibiting compound
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US6160122A (en) 1996-06-28 2000-12-12 Abbott Laboratories Process for the preparation of a disubstituted thiazole
ZA9710071B (en) 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
EP1183026B1 (en) * 1999-06-04 2006-07-05 Abbott Laboratories Improved pharmaceutical formulations comprising ritonavir

Also Published As

Publication number Publication date
KR100793046B1 (ko) 2008-01-10
CA2674800A1 (en) 2000-01-27
PT2017269E (pt) 2011-12-20
BR9912010A (pt) 2001-04-10
CN1310715B (zh) 2010-11-03
JP4815050B2 (ja) 2011-11-16
PT1418174E (pt) 2009-06-08
EP2298751A2 (en) 2011-03-23
WO2000004016A3 (en) 2000-03-30
SK922001A3 (en) 2001-07-10
TWI271400B (en) 2007-01-21
AR049658A2 (es) 2006-08-23
SI1097148T1 (en) 2004-10-31
MY121765A (en) 2006-02-28
NO20042393L (no) 2001-01-18
CA2510949A1 (en) 2000-01-27
NZ509125A (en) 2003-02-28
NO20010298D0 (no) 2001-01-18
CZ2001203A3 (en) 2001-05-16
CO5090830A1 (es) 2001-10-30
DK1097148T3 (da) 2004-04-26
CZ298188B6 (cs) 2007-07-18
IL191582A0 (en) 2008-12-29
CA2337846A1 (en) 2000-01-27
CN102153524A (zh) 2011-08-17
CA2510949C (en) 2009-11-17
CN1502613A (zh) 2004-06-09
JP2002520410A (ja) 2002-07-09
PL213978B1 (pl) 2013-05-31
HU227540B1 (en) 2011-08-29
DK1418174T3 (da) 2009-05-18
TR200100171T2 (tr) 2001-05-21
ES2214038T3 (es) 2004-09-01
KR20060118022A (ko) 2006-11-17
BG65150B1 (bg) 2007-04-30
BG105197A (en) 2001-10-31
ATE261947T1 (de) 2004-04-15
JP5732212B2 (ja) 2015-06-10
BG109682A (bg) 2007-03-30
ATE534636T1 (de) 2011-12-15
NZ522690A (en) 2004-04-30
CA2337846C (en) 2006-02-21
HU0800267D0 (en) 2008-06-30
TWI227713B (en) 2005-02-11
JP2014074047A (ja) 2014-04-24
EP1097148A2 (en) 2001-05-09
MY145265A (en) 2012-01-13
AR059764A2 (es) 2008-04-30
CY1112139T1 (el) 2015-11-04
CY1111600T1 (el) 2015-10-07
BG110080A (bg) 2008-11-28
BG66140B1 (bg) 2011-07-29
IL140492A (en) 2010-12-30
HU229999B1 (en) 2015-04-28
DE69915628T2 (de) 2004-08-12
PL194710B1 (pl) 2007-06-29
DE69915628D1 (en) 2004-04-22
EP2017269A3 (en) 2009-06-10
DK2017269T3 (da) 2012-03-05
CN101966180A (zh) 2011-02-09
BG65963B1 (bg) 2010-07-30
AU768207B2 (en) 2003-12-04
PT1097148E (pt) 2004-05-31
HK1037918A1 (en) 2002-02-22
HUP0103823A3 (en) 2003-05-28
SI1418174T1 (sl) 2009-08-31
KR100740796B1 (ko) 2007-07-20
HU0800266D0 (en) 2008-06-30
IL191582A (en) 2016-02-29
SK287586B6 (sk) 2011-03-04
EP1418174A3 (en) 2004-06-23
IL187181A (en) 2009-09-01
NO20010298L (no) 2001-01-18
EP2017269A9 (en) 2009-10-14
AR044029A2 (es) 2005-08-24
JP2017061475A (ja) 2017-03-30
CN101259128A (zh) 2008-09-10
SK287381B6 (sk) 2010-08-09
IL140492A0 (en) 2002-02-10
KR20040081137A (ko) 2004-09-20
DE69940616D1 (de) 2009-04-30
IL187181A0 (en) 2008-02-09
AU5003799A (en) 2000-02-07
AR019431A1 (es) 2002-02-20
EP2298751A3 (en) 2011-08-17
JP2010270135A (ja) 2010-12-02
NO318385B1 (no) 2005-03-14
EP2017269B1 (en) 2011-11-23
KR20010072003A (ko) 2001-07-31
AR059763A2 (es) 2008-04-30
EP2017269A8 (en) 2009-09-30
CZ2006533A3 (cs) 2001-05-16
NO327320B1 (no) 2009-06-08
SK286388B6 (sk) 2008-09-05
TW200716550A (en) 2007-05-01
HK1121155A1 (en) 2009-04-17
CN1310715A (zh) 2001-08-29
EP2017269A2 (en) 2009-01-21
CZ307116B6 (cs) 2018-01-24
HU230150B1 (hu) 2015-09-28
EP1418174A2 (en) 2004-05-12
ES2322759T3 (es) 2009-06-26
ES2372990T3 (es) 2012-01-30
HUP0103823A2 (hu) 2002-02-28
SI2017269T1 (sl) 2012-02-29
TWI362382B (en) 2012-04-21
EP1097148B1 (en) 2004-03-17
KR100853371B1 (ko) 2008-08-22
PL348033A1 (en) 2002-05-06
ATE425974T1 (de) 2009-04-15
WO2000004016A2 (en) 2000-01-27
EP1418174B1 (en) 2009-03-18

Similar Documents

Publication Publication Date Title
ID27996A (id) Polimorf dari suatu bahan farmasi
ID24962A (id) Turunan-turunan sulfonamida sebagai bakal obat dari
ID27040A (id) Bentuk sediaan dengan pelepasan berpulsa dari bahan farmasi oral
EE05063B1 (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
DE69827987D1 (de) Verpackungsmaterial
NO20005218L (no) Farmasöytisk aerosolpreparat
DE60011720D1 (de) Verbindungsmaterial
DK1466615T3 (da) Farmaceutisk præparat
ID26137A (id) Komposisi farmasi baru dari uridin trifosfat
DE69922710D1 (de) Gasadsorbierendes material
ID27150A (id) Sediaan levotiroksin bahan farmasi
FI972210A0 (fi) Icke-svettdrivande material
EE9900545A (et) Farmatseutiline kompositsioon
EE05331B1 (et) Bensamiididerivaati sisaldav farmatseutiline preparaat
DE60128783D1 (de) Stoffdichtung
NO994619L (no) Farmasöytiske blandinger
DE69803996D1 (de) Verpackungsmaterial
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
DE69919228D1 (de) Mehrschichtiges versiegelungsmaterial
NO20003141D0 (no) Farmasøytiske blandinger
NO991727D0 (no) Materialutlegger
ID23885A (id) Bentuk-bentuk polimorf baru dari cypamfylline
DE59813503D1 (de) Elektrodenmaterial
NO20013232L (no) Faststoffmateriale
ID23531A (id) Komposisi farmasi